CMS has published its proposed rule for the Physician Payments Sunshine Act, under which payments made by pharmaceutical, medical device or other supply manufacturers to physicians and teaching hospitals must be reported.
The proposed rule would also require the reporting of financial relationships between physicians, manufacturers and group purchasing organizations. The definition of GPOs would also include physician-owned distributorships.
Under the Patient Protection and Affordable Care Act, violators of the Sunshine Act would be subject to civil monetary penalties of up to $150,000 annually for failing to report and up to $1 million for knowingly failing to report.
CMS will accept comments on the proposed rule until Feb. 17.
Learn more about the proposed rule for Physician Payments Sunshine Act.
Related Articles on Physicians, Payments and Transparency:
Massachusetts Bill Would Allow Drugmakers to Hold Dinner Parties for Physicians
Proposal to Weaken Ban on Companies’ Gifts to Physicians May Gain Momentum in 2012
HHS Delays Rule for Physician Payment Sunshine Act
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
